Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126904111 | 12690411 | 1 | I | 20160722 | 20160725 | 20160826 | 20160826 | PER | US-FRI-1000086537 | FOREST | 56.89 | YR | M | Y | 0.00000 | 20160826 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126904111 | 12690411 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10MG | K4958 | 21323 | 10 | MG | TABLET | QD | |||||
| 126904111 | 12690411 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | 40MG AM | 0 | |||||||||||
| 126904111 | 12690411 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 2.5MG | 0 | 2.5 | MG | QD | ||||||||
| 126904111 | 12690411 | 4 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 48MG | 0 | |||||||||||
| 126904111 | 12690411 | 5 | C | HUMIRA | ADALIMUMAB | 1 | 30MG Q 2 WEEKS | 0 | QOW | ||||||||||
| 126904111 | 12690411 | 6 | C | OMEGA 3 FISH OIL | FISH OILOMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 126904111 | 12690411 | 7 | C | PROBIOTICS | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 126904111 | 12690411 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 2000 IU | 0 | |||||||||||
| 126904111 | 12690411 | 9 | C | VITAMIN C | ASCORBIC ACID | 1 | 1000 MG | 0 | |||||||||||
| 126904111 | 12690411 | 10 | C | COQ 10 | UBIDECARENONE | 1 | 200MG | 0 | |||||||||||
| 126904111 | 12690411 | 11 | C | BAYER ASPIRIN | ASPIRIN | 1 | 325MG | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126904111 | 12690411 | 1 | Anxiety |
| 126904111 | 12690411 | 2 | Hypertension |
| 126904111 | 12690411 | 3 | Hypertension |
| 126904111 | 12690411 | 4 | Blood triglycerides |
| 126904111 | 12690411 | 5 | Psoriasis |
| 126904111 | 12690411 | 6 | Supplementation therapy |
| 126904111 | 12690411 | 7 | Supplementation therapy |
| 126904111 | 12690411 | 8 | Supplementation therapy |
| 126904111 | 12690411 | 9 | Supplementation therapy |
| 126904111 | 12690411 | 10 | Supplementation therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126904111 | 12690411 | Anxiety | |
| 126904111 | 12690411 | Dizziness | |
| 126904111 | 12690411 | Headache | |
| 126904111 | 12690411 | Insomnia | |
| 126904111 | 12690411 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126904111 | 12690411 | 1 | 20160722 | 0 |